159. Voices of CEO Excellence: Merck’s Ken Fr...

Generative and agentic AI are moving rapidly from experimentation to enterprise-wide transformation—but many CEOs are still grappling with what this really means for their business. In this episode, McKinsey experts Tanguy Catlin, Sandra Durth, Lari Hämäläinen, and Antoine Montar ...  Show more

For new CEOs, engaging stakeholders is one of the most important—and most challenging—parts of the job. In this episode, Carolyn Dewar, Blair Epstein, and Eric Sherman discuss how CEOs can build a strong stakeholder strategy from day one. Drawing on research and their work with l ...  Show more

Active users of generative AI are high value and in demand—and in many cases, poised to quit. New research rev ...

Over the past several years, CEOs have faced mounting uncertainty–and 2024 is proving no exception. On this episode of The McKinsey Podcast, Homayoun Hatami, McKinsey's managing partner for client capabilities, and Liz Hilton Segel, McKinsey's chief client officer, sp ...

Over the past few years, CEOs have found themselves repeatedly recalibrating in the wake of shock after shock. As 2023 shapes up to be another year of uncertainty, stable ground may continue to seem elusive. In this episode of <a href="https://preview.mckinsey.com/featured ...

Ken Frazier, the longtime CEO of pharmaceutical giant Merck, was one of the few Black CEOs at the top of Corporate America. Now as an adviser at General Catalyst and co-founder of the social impact organization OneTen, he’s re-shaping how business addresses racial and health e ...